Central European Time

Scientific Program

WEDNESDAY, MAY 5, 2021
Breast Cancer

ON-SITE (ONLY) IN BERLIN: AUDITORIUM OF THE LANGENBECK VIRCHOW HAUS

INTENSIVE WORKSHOP

Breast Surgery Slide and Video Session
Moderation: J.-U. Blohmer and O. Camara

Breast and Axillary Surgery After Neoadjuvant Chemotherapy
J. Heil

Instead of Wire Markers: Types of Seeds
S.Paepke

Robotic Breast Surgery
B. Sarfati

NSME and Implant-based Breast Reconstruction with ADM or Synthetic Meshes
J.-U. Blohmer

Intraoperative Indocyanine Green Angiography (ICG-A)
M. Karsten

Lipofilling Breast Reconstruction
S. Kümmel

Free Flaps in Breast Reconstruction
O. Camara

Surgery of Lymphedema
H. Brorson


BREAK


ONLINE: LIVE STREAM OF THE PROGRAM (FREE OF CHARGE)

SATELLITE SYMPOSIUM (supported by Seagen)

Change in the Therapy Landscape at HER2-pos. MBC in the Context of the Current Guidelines – From a German and US-American Perspective
J.-U. Blohmer, S. Kümmel, C. O’Sullivan, A. Schneeweiss


GREETING WORDS

Welcome Address by Prof. Dr. Heyo K. Kroemer,
Chairman of the Executive Board, Charité – Universitätsmedizin Berlin


LOCAL THERPAY OF BREAST CANCER

Chairs: J. Heil, S. Paepke


German Perspective on Current Technical Aspects of Breast Cancer Surgery
S. Kümmel


Charité Perspective on Technical Aspects of Risk-reducing Breast Surgery
J.-U. Blohmer


Breast and Axillary Surgery After Neoadjuvant Chemotherapy
► Mayo Perspective: J.C. Boughey
► German Perspective: J. Heil


Mayo Perspective on Radiotherapy After Implant-based Breast Reconstruction
R.W. Mutter


Discussion


Mayo Perspective on Lymphedema After Breast Cancer Surgery: Prevention, Detection and Treatment
S.A. McLaughlin


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY I

Chairs: S. Kümmel, R.A. Leon Ferre


What Drives Metastases in Breast Cancer?
► American AURORA Program: S. Oesterreich and A. Lee
► German CATCH Program: A. Schneeweiss


Experiences with Patient-derived Xenografts and Cell Cultures and Organoids
► Mayo Perspective: L. Wang
► Charité Perspective: V. Kiver


Role of RNA and DNA Sequencing in Breast Cancer Therapy
U. Keilholz


Biomarkers to Guide Therapy of Breast Cancer Patients
► Mayo Perspective: J.M. Carter
► German Perspective: N. Harbeck


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY II

Chairs: D. Speiser, K. J. Ruddy


Presidential Lecture:
Endocrine Resistance in Early and Advanced Breast Cancer and Treatment Options After Tumor Progression under CDK4/6 Inhibition

M. P. Goetz


Immunotherapy for Whom and When?
► Mayo Perspective: R. A. Leon Ferre
► German Perspective: G. Pecher


Charité Perspective on HRD-related Therapies
D. Speiser


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY III

Chairs: M.P. Goetz, M. Karsten


Indications, Options, Algorithms in HER2+ Breast Cancer Therapy Today
J. Huober


Mayo Perspective on Prevention of Breast Cancer
A.C. Degnim


PATIENT REPORTED OUTCOME MEASURES IN BREAST CANCER THERAPY

Chairs: A.C. Degnim, U. Keilholz


PROMs in Medical Oncology: A New Study Endpoint / Management of Side Effects of Modern Drugs in Medical Oncology
► Mayo Perspective: K. J. Ruddy


PROMs in Breast Cancer Surgery and Follow-up
► Charité Perspective: M. Karsten


Summary of the Day
M.P. Goetz and J.-U. Blohmer



Afterwards:

Wappen

BERLIN CULTURAL HIGHLIGHT OF THE DAY

with Dr. med. Negin Karimian, Dermatologist and Singer

Fireside

FIRESIDE CHAT

with Prof. Dr. med. Werner Lichtenegger, Berlin (D)